128 related articles for article (PubMed ID: 32325093)
1. MitoTEMPO provides an antiarrhythmic effect in aged-rats through attenuation of mitochondrial reactive oxygen species.
Olgar Y; Billur D; Tuncay E; Turan B
Exp Gerontol; 2020 Jul; 136():110961. PubMed ID: 32325093
[TBL] [Abstract][Full Text] [Related]
2. Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance.
Olgar Y; Degirmenci S; Durak A; Billur D; Can B; Kayki-Mutlu G; Arioglu-Inan E E; Turan B
Exp Gerontol; 2018 Sep; 110():172-181. PubMed ID: 29908347
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Targeting Antioxidant Provides Cardioprotection through Regulation of Cytosolic and Mitochondrial Zn
Olgar Y; Tuncay E; Turan B
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382470
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide provides cardioprotection through the recovery of mitochondrial dysfunction and oxidative stress in aging hearts.
Durak A; Turan B
J Physiol Biochem; 2023 May; 79(2):297-311. PubMed ID: 36515811
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
[TBL] [Abstract][Full Text] [Related]
6. Resolution of mitochondrial oxidant stress improves aged-cardiovascular performance.
Owada T; Yamauchi H; Saitoh SI; Miura S; Machii H; Takeishi Y
Coron Artery Dis; 2017 Jan; 28(1):33-43. PubMed ID: 27740971
[TBL] [Abstract][Full Text] [Related]
7. Ageing-associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca
Olgar Y; Tuncay E; Degirmenci S; Billur D; Dhingra R; Kirshenbaum L; Turan B
J Cell Mol Med; 2020 Aug; 24(15):8567-8578. PubMed ID: 32652890
[TBL] [Abstract][Full Text] [Related]
8. MitoTempo protects against nε-carboxymethyl lysine-induced mitochondrial dyshomeostasis and neuronal cells injury.
Carvalho C; Moreira PI
Free Radic Biol Med; 2024 Aug; 220():192-206. PubMed ID: 38734265
[TBL] [Abstract][Full Text] [Related]
9. SOD1 and MitoTEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery.
Liang HL; Sedlic F; Bosnjak Z; Nilakantan V
Free Radic Biol Med; 2010 Nov; 49(10):1550-60. PubMed ID: 20736062
[TBL] [Abstract][Full Text] [Related]
10. β
Tuncay E; Olgar Y; Durak A; Degirmenci S; Bitirim CV; Turan B
J Cell Physiol; 2019 Aug; 234(8):13370-13386. PubMed ID: 30613975
[TBL] [Abstract][Full Text] [Related]
11. Intermittent Hypoxia Prevents Myocardial Mitochondrial Ca
Chang JC; Lien CF; Lee WS; Chang HR; Hsu YC; Luo YP; Jeng JR; Hsieh JC; Yang KT
Cells; 2019 Jun; 8(6):. PubMed ID: 31181855
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathy.
Liu M; Gu L; Sulkin MS; Liu H; Jeong EM; Greener I; Xie A; Efimov IR; Dudley SC
J Mol Cell Cardiol; 2013 Jan; 54():25-34. PubMed ID: 23123323
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional regulation of Ca2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes.
Yan Y; Liu J; Wei C; Li K; Xie W; Wang Y; Cheng H
Cardiovasc Res; 2008 Jan; 77(2):432-41. PubMed ID: 18006452
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted antioxidant mitotempo protects mitochondrial function against amyloid beta toxicity in primary cultured mouse neurons.
Hu H; Li M
Biochem Biophys Res Commun; 2016 Sep; 478(1):174-180. PubMed ID: 27444386
[TBL] [Abstract][Full Text] [Related]
15. Through modulation of cardiac Ca
Larbig R; Reda S; Paar V; Trost A; Leitner J; Weichselbaumer S; Motloch KA; Wernly B; Arrer A; Strauss B; Lichtenauer M; Reitsamer HA; Eckardt L; Seebohm G; Hoppe UC; Motloch LJ
Exp Physiol; 2017 Jun; 102(6):650-662. PubMed ID: 28370799
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
[TBL] [Abstract][Full Text] [Related]
17. MitoTEMPO Prevents Oxalate Induced Injury in NRK-52E Cells via Inhibiting Mitochondrial Dysfunction and Modulating Oxidative Stress.
Zhang J; Wang Q; Xu C; Lu Y; Hu H; Qin B; Wang Y; He D; Li C; Yu X; Wang S; Liu J
Oxid Med Cell Longev; 2017; 2017():7528090. PubMed ID: 28116040
[TBL] [Abstract][Full Text] [Related]
18. Amorphous SiO2 nanoparticles promote cardiac dysfunction via the opening of the mitochondrial permeability transition pore in rat heart and human cardiomyocytes.
Lozano O; Silva-Platas C; Chapoy-Villanueva H; Pérez BE; Lees JG; Ramachandra CJA; Contreras-Torres FF; Lázaro-Alfaro A; Luna-Figueroa E; Bernal-Ramírez J; Gordillo-Galeano A; Benitez A; Oropeza-Almazán Y; Castillo EC; Koh PL; Hausenloy DJ; Lim SY; García-Rivas G
Part Fibre Toxicol; 2020 May; 17(1):15. PubMed ID: 32381100
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca
Durak A; Akkus E; Canpolat AG; Tuncay E; Corapcioglu D; Turan B
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):46-59. PubMed ID: 34519087
[TBL] [Abstract][Full Text] [Related]
20. Calcium Signaling and Reactive Oxygen Species in Mitochondria.
Bertero E; Maack C
Circ Res; 2018 May; 122(10):1460-1478. PubMed ID: 29748369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
